FullHope Biomedical Co.,Ltd. (TPEX:7773)
Taiwan · Delayed Price · Currency is TWD 29.35
+0.35 (1.21%)
At close: Jun 18, 2026
FullHope Biomedical Market Cap
FullHope Biomedical has a market cap or net worth of 1.17 billion as of June 18, 2026. Its market cap has decreased by -21.84% in one year.
Market Cap
1.17B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.35
Market Cap Chart
Since September 26, 2024, FullHope Biomedical's market cap has decreased from 2.19B to 1.17B, a decrease of -46.54%. That is a compound annual growth rate of -30.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.17B | -4.24% |
| Dec 31, 2025 | 1.22B | -21.71% |
| Dec 31, 2024 | 1.56B | -28.69% |
| Sep 26, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.65B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.49B |
| Tripartite Therapeutics | 8.11B |
| Intelligene | 6.61B |
| Uwell Biopharma | 6.43B |
| Obigen Pharma | 3.90B |
| Pet Pharm Biotech | 2.91B |
| BIONET Therapeutics | 2.58B |